Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 4, 2013, Pages 747-758

  Singh, Jaspreet ^a   Khan, Mushfiquddin ^a   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ABCD2; ALDP; Cytokine; Glia; Very long chain fatty acid; X ALD

Indexed keywords

ABC TRANSPORTER; ABCD1 PROTEIN; ABCD2 PROTEIN; CAFFEIC ACID PHENETHYL ESTER; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CHILD; CONTROLLED STUDY; FATTY ACID OXIDATION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REPORTER GENE; SCHOOL CHILD; SKIN FIBROBLAST;

ACETYLTRANSFERASES; ADRENOLEUKODYSTROPHY; ANIMALS; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; CAFFEIC ACIDS; CELLS, CULTURED; CHILD; FIBROBLASTS; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHENYLETHYL ALCOHOL;

EID: 84873455710     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.01.004     Document Type: Article

References (68)

1. H.W. Moser Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope Ann. Neurol. 34 1993 121 122
2. M. Contreras, J. Mosser, J.L. Mandel, P. Aubourg, and I. Singh The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein FEBS Lett. 344 1994 211 215
3. M. Contreras, T.K. Sengupta, F. Sheikh, P. Aubourg, and I. Singh Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes Arch. Biochem. Biophys. 334 1996 369 379
4. R. Ofman, I.M. Dijkstra, C.W. van Roermund, N. Burger, M. Turkenburg, A. van Cruchten, C.E. van Engen, R.J. Wanders, and S. Kemp The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy EMBO Mol. Med. 2 2010 90 97
5. A. Di Biase, R. Di Benedetto, C. Fiorentini, S. Travaglione, S. Salvati, L. Attorri, and D. Pietraforte Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis Neurochem. Int. 44 2004 215 221
6. S. Fourcade, J. Lopez-Erauskin, J. Galino, C. Duval, A. Naudi, M. Jove, S. Kemp, F. Villarroya, I. Ferrer, R. Pamplona, M. Portero-Otin, and A. Pujol Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy Hum. Mol. Genet. 17 2008 1762 1773
7. S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture Hum. Mol. Genet. 17 2008 1750 1761
8. J.K. Ho, H. Moser, Y. Kishimoto, and J.A. Hamilton Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy J. Clin. Invest. 96 1995 1455 1463
9. M. Khan, J. Singh, A.G. Gilg, T. Uto, and I. Singh Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy J. Lipid Res. 51 2010 1685 1695
10. J. Singh, M. Khan, and I. Singh Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy J. Lipid Res. 50 2009 135 147
11. A. Schluter, L. Espinosa, S. Fourcade, J. Galino, E. Lopez, E. Ilieva, L. Morato, M. Asheuer, T. Cook, A. McLaren, J. Reid, F. Kelly, S. Bates, P. Aubourg, E. Galea, and A. Pujol Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy Hum. Mol. Genet. 21 2012 1062 1077
12. M. Khan, K. Pahan, A.K. Singh, and I. Singh Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy J. Neurochem. 71 1998 78 87
13. E. Shapiro, W. Krivit, L. Lockman, I. Jambaque, C. Peters, M. Cowan, R. Harris, S. Blanche, P. Bordigoni, D. Loes, R. Ziegler, M. Crittenden, D. Ris, B. Berg, C. Cox, H. Moser, A. Fischer, and P. Aubourg Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy Lancet 356 2000 713 718
14. N. Cartier, S. Hacein-Bey-Abina, C.C. Bartholomae, G. Veres, M. Schmidt, I. Kutschera, M. Vidaud, U. Abel, L. Dal-Cortivo, L. Caccavelli, N. Mahlaoui, V. Kiermer, D. Mittelstaedt, C. Bellesme, N. Lahlou, F. Lefrere, S. Blanche, M. Audit, E. Payen, P. Leboulch, B. l'Homme, P. Bougneres, C. Von Kalle, A. Fischer, M. Cavazzana-Calvo, and P. Aubourg Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 326 2009 818 823
15. A. Netik, S. Forss-Petter, A. Holzinger, B. Molzer, G. Unterrainer, and J. Berger Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy Hum. Mol. Genet. 8 1999 907 913
16. A. Pujol, I. Ferrer, C. Camps, E. Metzger, C. Hindelang, N. Callizot, M. Ruiz, T. Pampols, M. Giros, and J.L. Mandel Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy Hum. Mol. Genet. 13 2004 2997 3006
17. J. Singh, M. Khan, and I. Singh HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes J. Lipid Res. 52 2011 2056 2069
18. I. Singh, K. Pahan, and M. Khan Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy FEBS Lett. 426 1998 342 346
19. T. Uto, M.A. Contreras, A.G. Gilg, and I. Singh Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts Dev. Neurosci. 30 2008 410 418
20. G.S. Pai, M. Khan, E. Barbosa, L.L. Key, J.R. Craver, J.K. Cure, R. Betros, and I. Singh Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients Mol. Genet. Metab. 69 2000 312 322
21. S. Fourcade, M. Ruiz, C. Guilera, E. Hahnen, L. Brichta, A. Naudi, M. Portero-Otin, G. Dacremont, N. Cartier, R. Wanders, S. Kemp, J.L. Mandel, B. Wirth, R. Pamplona, P. Aubourg, and A. Pujol Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy Hum. Mol. Genet. 19 2010 2005 2014
22. S. Kemp, H.M. Wei, J.F. Lu, L.T. Braiterman, M.C. McGuinness, A.B. Moser, P.A. Watkins, and K.D. Smith Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy Nat. Med. 4 1998 1261 1268
23. M.C. McGuinness, H.P. Zhang, and K.D. Smith Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy Mol. Genet. Metab. 74 2001 256 263
24. T. Nagaoka, A.H. Banskota, Y. Tezuka, I. Saiki, and S. Kadota Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26-L5 carcinoma cell line Bioorg. Med. Chem. 10 2002 3351 3359
25. G.F. Sud'ina, O.K. Mirzoeva, M.A. Pushkareva, G.A. Korshunova, N.V. Sumbatyan, and S.D. Varfolomeev Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties FEBS Lett. 329 1993 21 24
26. K. Natarajan, S. Singh, T.R. Burke Jr., D. Grunberger, and B.B. Aggarwal Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B Proc. Natl. Acad. Sci. U. S. A. 93 1996 9090 9095
27. 2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids Biochem. Pharmacol. 51 1996 395 402
28. L.H. Boudreau, J. Maillet, L.M. LeBlanc, J. Jean-Francois, M. Touaibia, N. Flamand, and M.E. Surette Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes PLoS One 7 2012 e31833
29. S.C. Barber, A. Higginbottom, R.J. Mead, S. Barber, and P.J. Shaw An in vitro screening cascade to identify neuroprotective antioxidants in ALS Free Radic. Biol. Med. 46 2009 1127 1138
30. M. Khan, C. Elango, M.A. Ansari, I. Singh, and A.K. Singh Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia J. Neurochem. 102 2007 365 377
31. D. Dayangac-Erden, G. Bora-Tatar, S. Dalkara, A.S. Demir, and H. Erdem-Yurter Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics Arch. Med. Sci. 7 2011 230 234
32. D. Grunberger, R. Banerjee, K. Eisinger, E.M. Oltz, L. Efros, M. Caldwell, V. Estevez, and K. Nakanishi Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis Experientia 44 1988 230 232
33. M. Hoshi, and Y. Kishimoto Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. Some properties and distribution of the -hydroxylation system J. Biol. Chem. 248 1973 4123 4130
34. K. Pahan, F.G. Sheikh, M. Khan, A.M. Namboodiri, and I. Singh Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes J. Biol. Chem. 273 1998 2591 2600
35. J.S. Won, M.R. Choi, and H.W. Suh Stimulation of astrocyte-enriched culture with C2 ceramide increases proenkephalin mRNA: involvement of cAMP-response element binding protein and mitogen activated protein kinases Brain Res. 903 2001 207 215
36. I. Singh, A.S. Paintlia, M. Khan, R. Stanislaus, M.K. Paintlia, E. Haq, A.K. Singh, and M.A. Contreras Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment Brain Res. 1022 2004 1 11
37. R. Wilson, and J.R. Sargent Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients J. Neurochem. 61 1993 290 297
38. S. Albet, M. Bentejac, S. Savary, C. Gondcaille, A. Netik, J. Berger, C. Szpirer, N. Troffer-Charlier, and M. Bugaut Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression Biochim. Biophys. Acta 1517 2001 257 269
39. L.T. Braiterman, P.A. Watkins, A.B. Moser, and K.D. Smith Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression Mol. Genet. Metab. 66 1999 91 99
40. E. Flavigny, A. Sanhaj, P. Aubourg, and N. Cartier Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy FEBS Lett. 448 1999 261 264
41. A. Holzinger, S. Kammerer, and A.A. Roscher Primary structure of human PMP69, a putative peroxisomal ABC-transporter Biochem. Biophys. Res. Commun. 237 1997 152 157
42. K. Kamijo, T. Kamijo, I. Ueno, T. Osumi, and T. Hashimoto Nucleotide sequence of the human 70 kDa peroxisomal membrane protein: a member of ATP-binding cassette transporters Biochim. Biophys. Acta 1129 1992 323 327
43. M. Asheuer, I. Bieche, I. Laurendeau, A. Moser, B. Hainque, M. Vidaud, and P. Aubourg Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy Hum. Mol. Genet. 14 2005 1293 1303
44. I. Singh, A.E. Moser, S. Goldfischer, and H.W. Moser Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy Proc. Natl. Acad. Sci. U. S. A. 81 1984 4203 4207
45. P. Sharp, D. Johnson, and A. Poulos Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain J. Neurochem. 56 1991 30 37
46. F. Valianpour, J.J. Selhorst, L.E. van Lint, A.H. van Gennip, R.J. Wanders, and S. Kemp Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry Mol. Genet. Metab. 79 2003 189 196
47. Y. Kishimoto, H.W. Moser, N. Kawamura, M. Platt, S.L. Pallante, and C. Fenselau Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin Biochem. Biophys. Res. Commun. 96 1980 69 76
48. P. Tvrdik, R. Westerberg, S. Silve, A. Asadi, A. Jakobsson, B. Cannon, G. Loison, and A. Jacobsson Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids J. Cell Biol. 149 2000 707 718
49. G. Lombard-Platet, S. Savary, C.O. Sarde, J.L. Mandel, and G. Chimini A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern Proc. Natl. Acad. Sci. U. S. A. 93 1996 1265 1269
50. M.C. McGuinness, D.E. Griffin, G.V. Raymond, C.A. Washington, H.W. Moser, and K.D. Smith Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy J. Neuroimmunol. 61 1995 161 169
51. J.M. Powers, Y. Liu, A.B. Moser, and H.W. Moser The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications J. Neuropathol. Exp. Neurol. 51 1992 630 643
52. A.S. Paintlia, A.G. Gilg, M. Khan, A.K. Singh, E. Barbosa, and I. Singh Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies Neurobiol. Dis. 14 2003 425 439
53. A. Sala, S. Zarini, and M. Bolla Leukotrienes: lipid bioeffectors of inflammatory reactions Biochemistry (Mosc.) 63 1998 84 92
54. M. Baarine, K. Ragot, E.C. Genin, H. El Hajj, D. Trompier, P. Andreoletti, M.S. Ghandour, F. Menetrier, M. Cherkaoui-Malki, S. Savary, and G. Lizard Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes J. Neurochem. 111 2009 119 131
55. J. Berger, S. Albet, M. Bentejac, A. Netik, A. Holzinger, A.A. Roscher, M. Bugaut, and S. Forss-Petter The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression Eur. J. Biochem. 265 1999 719 727
56. I. Ferrer, J.P. Kapfhammer, C. Hindelang, S. Kemp, N. Troffer-Charlier, V. Broccoli, N. Callyzot, P. Mooyer, J. Selhorst, P. Vreken, R.J. Wanders, J.L. Mandel, and A. Pujol Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage Hum. Mol. Genet. 14 2005 3565 3577
57. J. Traynor, P. Agarwal, L. Lazzeroni, and U. Francke Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations BMC Med. Genet. 3 2002 12
58. I. Singh, M. Khan, L. Key, and S. Pai Lovastatin for X-linked adrenoleukodystrophy N. Engl. J. Med. 339 1998 702 703
59. M. Hashmi, W. Stanley, and I. Singh Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy FEBS Lett. 196 1986 247 250
60. O. Lazo, M. Contreras, A. Bhushan, W. Stanley, and I. Singh Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency Arch. Biochem. Biophys. 270 1989 722 728
61. O. Lazo, M. Contreras, M. Hashmi, W. Stanley, C. Irazu, and I. Singh Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy Proc. Natl. Acad. Sci. U. S. A. 85 1988 7647 7651
62. W. Lageweg, J.E. Sykes, M. Lopes-Cardozo, and R.J. Wanders Oxidation of very-long-chain fatty acids in rat brain: cerotic acid is beta-oxidized exclusively in rat brain peroxisomes Biochim. Biophys. Acta 1085 1991 381 384
63. S. Fourcade, M. Ruiz, C. Camps, A. Schluter, S.M. Houten, P.A. Mooyer, T. Pampols, G. Dacremont, R.J. Wanders, M. Giros, and A. Pujol A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis Am. J. Physiol. Endocrinol. Metab. 296 2009 E211 E221
64. E.C. Genin, F. Geillon, C. Gondcaille, A. Athias, P. Gambert, D. Trompier, and S. Savary Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2) J. Biol. Chem. 286 2011 8075 8084
65. I. Singh, and A. Pujol Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis Brain Pathol. 20 2010 838 844
66. J. Jang, H.C. Kang, H.S. Kim, J.Y. Kim, Y.J. Huh, D.S. Kim, J.E. Yoo, J.A. Lee, B. Lim, J. Lee, T.M. Yoon, I.H. Park, D.Y. Hwang, G.Q. Daley, and D.W. Kim Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients Ann. Neurol. 70 2011 402 409
67. G. Wang, B.M. Daniel, and M.A. DeCoster Role of nitric oxide in regulating secreted phospholipase A2 release from astrocytes Neuroreport 16 2005 1345 1350
68. C.V. Fontanilla, Z. Ma, X. Wei, J. Klotsche, L. Zhao, P. Wisniowski, R.C. Dodel, M.R. Farlow, W.H. Oertel, and Y. Du Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration Neuroscience 188 2011 135 141